Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia.

C.N.S. Center for Neurovisceral Sciences & Women's Health, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
The American Journal of Gastroenterology (Impact Factor: 9.21). 06/2003; 98(6):1354-61. DOI: 10.1111/j.1572-0241.2003.07478.x
Source: PubMed

ABSTRACT Symptoms of irritable bowel syndrome (IBS) and fibromyalgia (FM) commonly coexist. We hypothesized that one of the mechanisms underlying this comorbidity is increased activation of brain regions concerned with the processing and modulation of visceral and somatic afferent information, in particular subregions of the anterior cingulate cortex (ACC).
Regional cerebral blood flow (rCBF) was assessed in age-matched female IBS (n = 10) and IBS + FM (n = 10) subjects using H(2)(15)O positron emission tomography during noxious visceral (rectal) and somatic pressure stimuli.
GI symptom severity was significantly higher in the IBS patients compared with the IBS + FM patients (p < 0.05). In addition, IBS + FM patients rated somatic pain as more intense than their abdominal pain (p < 0.05). Whereas the somatic stimulus was less unpleasant than the visceral stimulus for IBS patients without FM, the somatic and visceral stimuli were equally unpleasant in the IBS + FM group. Group differences in regional brain activation were entirely within the middle subregion of the ACC. There was a greater rCBF increase in response to noxious visceral stimuli in IBS patients and to somatic stimuli in IBS + FM patients.
Chronic stimulus-specific enhancement of ACC responses to sensory stimuli in both syndromes may be associated with cognitive enhancement of either visceral (IBS) or somatic (IBS + FM) sensory input and may play a key pathophysiologic role in these chronic pain syndromes.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Widespread hyperalgesia is well documented among adult patients with Irritable Bowel Syndrome (IBS), but little is known about pain sensitivity among adolescents with IBS. We examined pain sensitivity in 961 adolescents from the general population (mean age 16.1 years), including pain threshold and tolerance measurements of heat (forearm) and pressure pain (fingernail and shoulder), and cold-pressor tolerance (hand). Adolescents with IBS symptoms (Rome III criteria) had lower heat pain thresholds compared to controls after adjustments for sex, co-morbid pain and psychological distress (mean difference = -0.8 (o)C; 95% CI = -1.6 to -0.04). Similar results were found for pressure pain threshold at the shoulder (mean difference = -46 kPa; 95% CI = -78 to -13) and fingernail (mean difference = -62 kPa; 95% CI = -109 to -15), and for an aggregate of all three threshold measures (z-score difference = -0.4; 95% CI = -0.6 to -0.2), though pressure pain threshold differences were non-significant after the final adjustments for psychological distress. No difference of pain tolerance was found between the IBS cases and controls. Our results indicate that adolescents in the general population with IBS symptoms, like adults, have widespread hyperalgesia.
    Journal of Pain 06/2014; DOI:10.1016/j.jpain.2014.05.007 · 4.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mast cells expressed the substance P NK1 receptor and the calcitonin gene-related peptide (CGRP) receptor in guinea pig and human small intestine. Enzyme-linked immuno assay (ELISA) showed that activation of intramural afferents by antidromic electrical stimulation or by capsaicin, released substance P and CGRP from human and guinea pig intestinal segments. Electrical stimulation of the afferents evoked slow excitatory postsynaptic potentials (slow EPSPs) in the enteric nervous system (ENS). The slow EPSPs were mediated by tachykinin NK1 and CGRP receptors. Capsaicin evoked slow EPSP-like responses that were suppressed by antagonists for protease activated receptor 2. Afferent stimulation evoked slow EPSP-like excitation that was suppressed by mast cell stabilizing drugs. Histamine and mast cell protease II were released by: i) exposure to substance P or CGRP; ii) capsaicin; iii) compound 48/80; iv) elevation of mast cell Ca(2+) by ionophore, A23187; v) antidromic electrical stimulation of afferents. The mast cell stabilizers, cromolyn or doxantrazole, suppressed release of protease II and histamine when evoked by substance P, CGRP, capsaicin, A23187, electrical stimulation of afferents or compound 48/80. Neural blockade by tetrodotoxin prevented mast cell protease II release in response to antidromic electrical stimulation of mesenteric afferents. The results support a hypothesis that afferent innervation of enteric mast cells releases histamine and mast cell protease II, both of which are known to act in diffuse paracrine manner to influence the behavior of ENS neurons and to elevate the sensitivity of spinal afferent terminals.
    AJP Gastrointestinal and Liver Physiology 08/2014; 307(7). DOI:10.1152/ajpgi.00125.2014 · 3.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: 07-09-2007 This information is excerpted with kind permission from a highly rated new educational guide to FM management – Fibromyalgia: The Complete Guide from Medical Experts and Patients (May 2007, Jones and Bartlett), by Dr. Sharon Ostalecki, PhD.* ___________________ Irritable bowel syndrome (IBS) is a gastrointestinal disorder present in 33% to 77% of individuals with Fibromyalgia.1 This prevalence rate is far higher than the 10% to 15% rate of IBS in the general population.2 This chapter reviews the nature, impact, and treatment of IBS. It also discusses the efforts researchers are making to understand the causes and implications of the surprisingly frequent coexistence of IBS and Fibromyalgia in the same individuals. The Nature of IBS The diagnosis of IBS is based on a specific cluster of bowel symptoms, primarily recurrent or persistent abdominal pain associated with diarrhea, constipation, or both. Secondary symptoms, such as bloating or the sudden urge to defecate, are also associated with the disorder. Such "supportive symptoms" give doctors more confidence in the diagnosis. A committee of international experts has set criteria (called the "Rome criteria") for the type and frequency of bowel symptoms that warrant a definite diagnosis of IBS. IBS is one of several "functional" gastrointestinal disorders. A functional disorder is one in which no structural abnormality can be found, but function is disturbed. Therefore, a confident diagnosis generally requires a careful medical evaluation. Sometimes medical tests, such as blood tests or endoscopy, are also needed to rule out biological problems that could account for the symptoms.

Full-text (2 Sources)

Available from
Jun 2, 2014

Similar Publications